{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:34:50Z","timestamp":1787758490732,"version":"build-2784847793"},"reference-count":25,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21CC0073729"],"award-info":[{"award-number":["NNF21CC0073729"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity\u2010free survival (STFS) framework to determine the prevalence of 21 physician\u2010defined severe toxicities following ALL treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective cohort study. Inclusion: (i) pediatric patients (0\u201318 years), (ii) treated for ALL at the Royal Children's Hospital, Melbourne, Australia, (iii) treated prior to December 2019, and (iv) &gt;5 years since diagnosis (Dx). Exclusion criteria: (i) pediatric patients with ALL but did not receive treatment, (ii) &lt;5 years since ALL Dx. Toxicity data were captured following review of the patients electronic medical record (EMR) using a list of 21 defined unacceptable toxicities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 345 patients who received primary ALL treatment at the Royal Children's Hospital, meeting the inclusion criteria of this study. The median age at Dx was 4 years (QR 3\u20139), and 161 patients (46.7%) were female. A total of 78 patients (22.6%) were identified as having a severe toxicity associated with their ALL treatment. The most common toxicities observed are mental health concerns (9.6%), osteonecrosis (6.7%), and paralytic, neuropathic, myopathic, and movement disorders (4.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study reveals that 22.6% of patients with ALL experienced severe toxicities according to the STFS endpoint. The prominence of mental health concerns, osteonecrosis, and various movement disorders highlights the diverse nature of these toxicities. Given their severity and breadth, ongoing surveillance and intervention should be incorporated into standard care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/1545-5017.70450","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:26:52Z","timestamp":1784662012000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of 21 Physician\u2010Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study"],"prefix":"10.1002","volume":"73","author":[{"given":"Lane","family":"Collier","sequence":"first","affiliation":[{"name":"Cancer Therapies, Stem Cell Medicine Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Grantham","sequence":"additional","affiliation":[{"name":"Cancer Therapies, Stem Cell Medicine Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Neuro\u2010Oncology, Stem Cell Medicine Murdoch Children's Research Institute  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Grud","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Lundgren","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liv","family":"Andr\u00e9s\u2010Jensen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen University Hospital  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Selman","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology and Biostatistics Unit Murdoch Children's Research Institute  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Ball","sequence":"additional","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"Developmental Imaging Murdoch Children's Research Institute  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse","family":"Passmore","sequence":"additional","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"Developmental Imaging Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Gait Analysis Laboratory The Royal Children's Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Elliott","sequence":"additional","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"Heart Regeneration, Stem Cell Medicine Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"The Novo Nordisk Foundation Centre for Stem Cell Medicine, reNEW Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Australian Regenerative Medicine Institute Monash University  Clayton Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Conyers","sequence":"additional","affiliation":[{"name":"Cancer Therapies, Stem Cell Medicine Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"The Novo Nordisk Foundation Centre for Stem Cell Medicine, reNEW Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Children's Cancer Centre The Royal Children's Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510795"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00460-3"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10072-x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-85147-7_12"},{"issue":"1","key":"e_1_2_8_6_1","first-page":"59","article-title":"Late Adverse Effects After Treatment for Childhood Acute Leukemia","volume":"53","author":"Roganovic J.","year":"2024","journal-title":"Acta Medica Academica"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30050-X"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00493"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00136-8"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1155449"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24559"},{"key":"e_1_2_8_13_1","unstructured":"Services Australia Mental Health Care and Medicare(Services Australia 2025) https:\/\/www.servicesaustralia.gov.au\/mental\u2010health\u2010care\u2010and\u2010medicare?context=60092."},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25773"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9564"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017007286"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70274-7"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1530\/EC-24-0487"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-021-04316-z"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2023.08.002"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12984-021-00818-2"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30035-3"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzz176"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2023.2168"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-7584-3_26"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02339-y"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70450","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/1545-5017.70450","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/1545-5017.70450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:16:00Z","timestamp":1787757360000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/1545-5017.70450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/1545-5017.70450"],"URL":"https:\/\/doi.org\/10.1002\/1545-5017.70450","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"2025-10-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70450"}}